Annual Shareholders Equity
-$7.98 M
-$12.83 M-264.42%
December 31, 2023
Summary
- As of February 8, 2025, SLS annual stockholders equity is -$7.98 million, with the most recent change of -$12.83 million (-264.42%) on December 31, 2023.
- During the last 3 years, SLS annual shareholders equity has fallen by -$35.94 million (-128.53%).
- SLS annual shareholders equity is now -121.52% below its all-time high of $37.06 million, reached on December 31, 2014.
Performance
SLS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$15.89 M
+$12.98 M+445.55%
September 30, 2024
Summary
- As of February 8, 2025, SLS quarterly stockholders equity is $15.89 million, with the most recent change of +$12.98 million (+445.55%) on September 30, 2024.
- Over the past year, SLS quarterly shareholders equity has increased by +$23.87 million (+299.25%).
- SLS quarterly shareholders equity is now -73.10% below its all-time high of $59.08 million, reached on March 31, 2015.
Performance
SLS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
SLS Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -264.4% | +299.3% |
| 3 y3 years | -128.5% | +228.1% |
| 5 y5 years | -252.1% | +228.1% |
SLS Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -139.2% | at low | -21.9% | +299.3% |
| 5 y | 5-year | -128.5% | at low | -52.4% | +299.3% |
| alltime | all time | -121.5% | at low | -73.1% | +250.3% |
SELLAS Life Sciences Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.89 M(+445.6%) |
| Jun 2024 | - | $2.91 M(-69.9%) |
| Mar 2024 | - | $9.68 M(-221.4%) |
| Dec 2023 | -$7.98 M(-264.4%) | -$7.98 M(+108.4%) |
| Sep 2023 | - | -$3.83 M(-179.0%) |
| Jun 2023 | - | $4.84 M(-63.2%) |
| Mar 2023 | - | $13.17 M(+171.5%) |
| Dec 2022 | $4.85 M(-76.2%) | $4.85 M(-61.5%) |
| Sep 2022 | - | $12.60 M(-33.9%) |
| Jun 2022 | - | $19.06 M(+373.5%) |
| Mar 2022 | - | $4.03 M(-80.2%) |
| Dec 2021 | $20.35 M(-27.2%) | $20.35 M(-23.5%) |
| Sep 2021 | - | $26.61 M(-20.4%) |
| Jun 2021 | - | $33.41 M(+16.3%) |
| Mar 2021 | - | $28.74 M(+2.8%) |
| Dec 2020 | $27.96 M(+358.9%) | $27.96 M(+251.8%) |
| Sep 2020 | - | $7.95 M(+110.1%) |
| Jun 2020 | - | $3.78 M(-53.1%) |
| Mar 2020 | - | $8.06 M(+32.3%) |
| Dec 2019 | $6.09 M(+16.2%) | $6.09 M(-42.7%) |
| Sep 2019 | - | $10.64 M(-25.8%) |
| Jun 2019 | - | $14.34 M(+386.0%) |
| Mar 2019 | - | $2.95 M(-43.8%) |
| Dec 2018 | $5.25 M(+153.4%) | $5.25 M(-71.6%) |
| Sep 2018 | - | $18.46 M(-843.3%) |
| Jun 2018 | - | -$2.48 M(+88.4%) |
| Mar 2018 | - | -$1.32 M(-163.7%) |
| Dec 2017 | $2.07 M(-141.4%) | $2.07 M(-85.9%) |
| Sep 2017 | - | $14.64 M(-23.5%) |
| Jun 2017 | - | $19.13 M(-29.7%) |
| Mar 2017 | - | $27.19 M(-644.2%) |
| Dec 2016 | -$5.00 M(-137.0%) | -$5.00 M(-120.9%) |
| Sep 2016 | - | $23.93 M(+17.8%) |
| Jun 2016 | - | $20.32 M(+63.7%) |
| Mar 2016 | - | $12.41 M(-8.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $13.51 M(-63.5%) | $13.51 M(-58.3%) |
| Sep 2015 | - | $32.42 M(-34.3%) |
| Jun 2015 | - | $49.37 M(-16.4%) |
| Mar 2015 | - | $59.08 M(+59.4%) |
| Dec 2014 | $37.06 M(+529.6%) | $37.06 M(+20.1%) |
| Sep 2014 | - | $30.86 M(+9.0%) |
| Jun 2014 | - | $28.31 M(-39.1%) |
| Mar 2014 | - | $46.50 M(+690.1%) |
| Dec 2013 | $5.89 M(-78.8%) | $5.89 M(-83.0%) |
| Sep 2013 | - | $34.62 M(+127.3%) |
| Jun 2013 | - | $15.23 M(-34.7%) |
| Mar 2013 | - | $23.31 M(-16.0%) |
| Dec 2012 | $27.76 M(+174.5%) | $27.76 M(+95.9%) |
| Sep 2012 | - | $14.16 M(-25.9%) |
| Jun 2012 | - | $19.12 M(-280.9%) |
| Mar 2012 | - | -$10.57 M(-204.5%) |
| Dec 2011 | $10.11 M(+316.1%) | $10.11 M(+114.7%) |
| Sep 2011 | - | $4.71 M(-52.2%) |
| Jun 2011 | - | $9.86 M(+205.2%) |
| Mar 2011 | - | $3.23 M(+33.0%) |
| Dec 2010 | $2.43 M(+227.9%) | $2.43 M(-26.1%) |
| Sep 2010 | - | $3.29 M(-48.9%) |
| Jun 2010 | - | $6.44 M(-6.9%) |
| Mar 2010 | - | $6.91 M(+832.7%) |
| Dec 2009 | $741.00 K(-91.7%) | $741.00 K(-87.1%) |
| Sep 2009 | - | $5.74 M(+78.1%) |
| Jun 2009 | - | $3.22 M(-50.2%) |
| Mar 2009 | - | $6.47 M(-27.8%) |
| Dec 2008 | $8.97 M(-17.1%) | $8.97 M(-26.4%) |
| Sep 2008 | - | $12.19 M(-14.8%) |
| Jun 2008 | - | $14.31 M(+62.5%) |
| Mar 2008 | - | $8.81 M(-18.6%) |
| Dec 2007 | $10.82 M(>+9900.0%) | $10.82 M(-14.7%) |
| Sep 2007 | - | $12.68 M(>+9900.0%) |
| Dec 2006 | $2000.00 | $2000.00 |
FAQ
- What is SELLAS Life Sciences annual stockholders equity?
- What is the all time high annual shareholders equity for SELLAS Life Sciences?
- What is SELLAS Life Sciences annual shareholders equity year-on-year change?
- What is SELLAS Life Sciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for SELLAS Life Sciences?
- What is SELLAS Life Sciences quarterly shareholders equity year-on-year change?
What is SELLAS Life Sciences annual stockholders equity?
The current annual shareholders equity of SLS is -$7.98 M
What is the all time high annual shareholders equity for SELLAS Life Sciences?
SELLAS Life Sciences all-time high annual stockholders equity is $37.06 M
What is SELLAS Life Sciences annual shareholders equity year-on-year change?
Over the past year, SLS annual stockholders equity has changed by -$12.83 M (-264.42%)
What is SELLAS Life Sciences quarterly stockholders equity?
The current quarterly shareholders equity of SLS is $15.89 M
What is the all time high quarterly shareholders equity for SELLAS Life Sciences?
SELLAS Life Sciences all-time high quarterly stockholders equity is $59.08 M
What is SELLAS Life Sciences quarterly shareholders equity year-on-year change?
Over the past year, SLS quarterly stockholders equity has changed by +$23.87 M (+299.25%)